Nymox Pharmaceutical
NYMX
#10675
Rank
โ‚น1.74 B
Marketcap
Country
โ‚น19.07
Share price
0.00%
Change (1 day)
N/A
Change (1 year)

EPS for Nymox Pharmaceutical (NYMX)

EPS in 2023 (TTM): -โ‚น4.92

According to Nymox Pharmaceutical's latest financial reports the company's current EPS (TTM) is -โ‚น5.72. In 2022 the company made an earnings per share (EPS) of -โ‚น7.63 an increase over its 2021 EPS that were of -โ‚น14.31.

EPS history for Nymox Pharmaceutical from 1997 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-โ‚น4.92-35.52%
2022-โ‚น7.63-46.67%
2021-โ‚น14.31-11.76%
2020-โ‚น16.21-15%
2019-โ‚น19.075.26%
2018-โ‚น18.12-26.92%
2017-โ‚น24.80-7.14%
2016-โ‚น26.70-40.43%
2015-โ‚น44.82291.67%
2014-โ‚น11.44-7.69%
2013-โ‚น12.40-43.48%
2012-โ‚น21.93-25.81%
2011-โ‚น29.5655%
2010-โ‚น19.0725%
2009-โ‚น15.260.08%
2008-โ‚น15.25-11.12%
2007-โ‚น17.16-0.16%
2006-โ‚น17.1828.59%
2005-โ‚น13.36-12.49%
2004-โ‚น15.27-16.05%
2003-โ‚น18.1919.07%
2002-โ‚น15.2814.45%
2001-โ‚น13.35-22.16%
2000-โ‚น17.155.64%
1999-โ‚น16.23-34.59%
1998-โ‚น24.82-3.6%
1997-โ‚น25.74

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น833.01-14,657.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น124.93-2,283.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น344.14-6,114.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2,692-47,142.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚น874.52-15,383.33%๐Ÿ‡บ๐Ÿ‡ธ USA